Additionally, polymorphisms in the HMOX1 promoter that correspond to increased HO-1 levels have been correlated with reduced incidents of acute chest syndrome in pediatric SCD patients and overall reductions in vaso-occlusive pain crises and hospitalization rates (13, 14). This evidence concerns the gene HMOX1 and Schnyder corneal dystrophy.